Dan L. Longo

42.4k total citations · 6 hit papers
365 papers, 25.3k citations indexed

About

Dan L. Longo is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Dan L. Longo has authored 365 papers receiving a total of 25.3k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Immunology, 97 papers in Oncology and 89 papers in Molecular Biology. Recurrent topics in Dan L. Longo's work include Immune Cell Function and Interaction (78 papers), Lymphoma Diagnosis and Treatment (65 papers) and T-cell and B-cell Immunology (63 papers). Dan L. Longo is often cited by papers focused on Immune Cell Function and Interaction (78 papers), Lymphoma Diagnosis and Treatment (65 papers) and T-cell and B-cell Immunology (63 papers). Dan L. Longo collaborates with scholars based in United States, Italy and United Kingdom. Dan L. Longo's co-authors include Dennis D. Taub, William J. Murphy, J. Larry Jameson, Elaine S. Jaffe, Luigi Ferrucci, Walter J. Urba, Jack M. Guralnik, Bruce A. Chabner, P L Duffey and Joost J. Oppenheim and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Dan L. Longo

361 papers receiving 24.5k citations

Hit Papers

Impact of caloric restriction on h... 1992 2026 2003 2014 2012 2004 2015 1992 2006 250 500 750

Peers

Dan L. Longo
Dennis A. Carson United States
Gary S. Firestein United States
Paul P. Tak Netherlands
Peter E. Lipsky United States
Raymond A. Sobel United States
Lee M. Nadler United States
Dennis A. Carson United States
Dan L. Longo
Citations per year, relative to Dan L. Longo Dan L. Longo (= 1×) peers Dennis A. Carson

Countries citing papers authored by Dan L. Longo

Since Specialization
Citations

This map shows the geographic impact of Dan L. Longo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan L. Longo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan L. Longo more than expected).

Fields of papers citing papers by Dan L. Longo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan L. Longo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan L. Longo. The network helps show where Dan L. Longo may publish in the future.

Co-authorship network of co-authors of Dan L. Longo

This figure shows the co-authorship network connecting the top 25 collaborators of Dan L. Longo. A scholar is included among the top collaborators of Dan L. Longo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan L. Longo. Dan L. Longo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalechman, Yona, Hagit Hauschner, Tal Cohen, et al.. (2024). Inhibition of α4β1 Integrin Activity by Small Tellurium Compounds Regulates PD-L1 Expression and Enhances Antitumor Effects. International Journal of Biological Sciences. 20(11). 4407–4423. 1 indexed citations
2.
Le, Catherine T., Cordelia Dunai, Lam T. Khuat, et al.. (2023). Regulation of human and mouse bystander T cell activation responses by PD-1. JCI Insight. 8(18). 6 indexed citations
3.
Khuat, Lam T., Cordelia Dunai, Shyam K. More, et al.. (2021). Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects. Blood. 138(24). 2583–2588. 9 indexed citations
4.
Chabner, Bruce A. & Dan L. Longo. (2018). Cancer Chemotherapy, Immunotherapy and Biotherapy: Principles and Practice, 6e. 1 indexed citations
5.
Shanker, Anil, Samuel T. Pellom, Menaka C. Thounaojam, et al.. (2015). Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity. Cancer Research. 75(24). 5260–5272. 23 indexed citations
6.
Kalechman, Yona, et al.. (2014). Sensitizing B- and T- cell Lymphoma Cells to Paclitaxel/Abraxane–Induced Death by AS101 via Inhibition of the VLA-4–IL10–Survivin Axis. Molecular Cancer Research. 13(3). 411–422. 16 indexed citations
7.
Berrébi, Alain, Maor H. Pauker, Alon Silberman, et al.. (2014). Redox Modulation of Adjacent Thiols in VLA-4 by AS101 Converts Myeloid Leukemia Cells from a Drug-Resistant to Drug-Sensitive State. Cancer Research. 74(11). 3092–3103. 60 indexed citations
8.
Correa-Cerro, Lina S., Yulan Piao, Alexei A. Sharov, et al.. (2011). Generation of mouse ES cell lines engineered for the forced induction of transcription factors. Scientific Reports. 1(1). 167–167. 38 indexed citations
9.
Siervi, Adriana De, Paola De Luca, Jung S. Byun, et al.. (2010). Transcriptional Autoregulation by BRCA1. Cancer Research. 70(2). 532–542. 60 indexed citations
10.
Byun, Jung S., Madeline Wong, Wenwu Cui, et al.. (2009). Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes. Proceedings of the National Academy of Sciences. 106(46). 19286–19291. 52 indexed citations
11.
Kaneda, Atsushi, Raymond Cheong, Winston Timp, et al.. (2007). Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk. Proceedings of the National Academy of Sciences. 104(52). 20926–20931. 86 indexed citations
12.
Sasaki, Carl Y., et al.. (2007). Traf1 Induction and Protection from Tumor Necrosis Factor by Nuclear Factor-κB p65 Is Independent of Serine 536 Phosphorylation. Cancer Research. 67(23). 11218–11225. 9 indexed citations
13.
Ghosh, Paritosh, et al.. (2004). Comparison of the Effect of Mutant and Wild-Type p53 on Global Gene Expression. Cancer Research. 64(22). 8199–8207. 43 indexed citations
14.
Yano, Shingo, Paritosh Ghosh, Hitoshi Kusaba, M Buchholz, & Dan L. Longo. (2003). Effect of Promoter Methylation on the Regulation of IFN- γ Gene During In Vitro Differentiation of Human Peripheral Blood T Cells into a Th2 Population. The Journal of Immunology. 171(5). 2510–2516. 98 indexed citations
15.
Hu, Lina, Louis J. Rezanka, Qing‐Sheng Mi, et al.. (2002). T15-Idiotype-Negative B Cells Dominate the Phosphocholine Binding Cells in the Preimmune Repertoire of T15i Knockin Mice. The Journal of Immunology. 168(3). 1273–1280. 6 indexed citations
16.
Sieckmann, Donna G., E. Martin, G Guelde, Dan L. Longo, & James J. Kenny. (1997). Anti-Idiotype Monoclonal Antibodies Specific for the MOPC167 Anti-Phosphocholine Transgene-Encoded Antibody. Hybridoma. 16(6). 503–511. 2 indexed citations
17.
Ershler, William B. & Dan L. Longo. (1997). Aging and Cancer: Issues of Basic and Clinical Science. JNCI Journal of the National Cancer Institute. 89(20). 1489–1497. 112 indexed citations
18.
Linnekin, Diana, Sherry Mou, Sarah R. Weiler, et al.. (1997). Stem Cell Factor, the JAK-STAT Pathway and Signal Transduction. Leukemia & lymphoma. 27(5-6). 439–444. 41 indexed citations
19.
Muraguchi, Atsushi, John H. Kehrl, Dan L. Longo, et al.. (1985). Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function.. The Journal of Experimental Medicine. 161(1). 181–197. 211 indexed citations
20.
Blayney, Douglas W. & Dan L. Longo. (1983). Ovarian cancer: epidemiology, diagnosis, and management.. PubMed. 9(1). 50–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026